Effect of acid-sensing ion channel 1a on the process of liver fibrosis under hyperglycemia
Creators
- 1. Institute for Liver Diseases of Anhui Medical University (AMU), Anhui Medical University, Hefei, 230032 (China)
- 2. School of Pharmacy, Anhui Medical University, Hefei, 230032 (China)
Description
Metabolic syndrome characterized by hyperglycemia contributes to nonalcoholic steatohepatitis-associated liver fibrosis. This study was to investigate the effects of Acid-sensing ion Channel 1a (ASIC1a) on the process of liver fibrosis under hyperglycemia. Results showed that high glucose significantly worsen the pathology of liver fibrosis in vivo. In vitro, high glucose stimulated proliferation, activation and extracellular matrix (ECM) production in HSCs, and enhanced the effect of PDGF-BB on the activation and proliferation of HSCs. These effects could be attenuated by ASIC1a specific inhibitor Psalmotoxin-1(PcTx1) or specific ShRNA for ASIC1a through Notch1/Hes-1 pathways. These data indicate that ASIC1a plays an important role in diabetes complication liver fibrosis. - Highlights: • Hyperglycemia is a risk factor for the process of liver fibrosis. • ASIC1a may be a key factor linking between high glucose and liver fibrosis. • Notch1/Hes-1 may involve to the process of liver fibrosis under hyperglycemia.
Availability note (English)
Available from http://dx.doi.org/10.1016/j.bbrc.2015.11.029Additional details
Identifiers
- DOI
- 10.1016/j.bbrc.2015.11.029;
- PII
- S0006-291X(15)30899-8;
Publishing Information
- Journal Title
- Biochemical and Biophysical Research Communications
- Journal Volume
- 468
- Journal Issue
- 4
- Journal Page Range
- p. 758-765
- ISSN
- 0006-291X
- CODEN
- BBRCA9
INIS
- Country of Publication
- United States
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 48038767
- Subject category
- S60: APPLIED LIFE SCIENCES;
- Descriptors DEI
- ACTIN; DIABETES MELLITUS; FIBROSIS; GLUCOSE; HAZARDS; HYPERGLYCEMIA; IN VITRO; IN VIVO; LIVER; MUSCLES; PATHOLOGY; RNA; STREPTOZOCIN
- Descriptors DEC
- ALDEHYDES; ANTIBIOTICS; ANTI-INFECTIVE AGENTS; ANTINEOPLASTIC DRUGS; BODY; CARBOHYDRATES; DIGESTIVE SYSTEM; DISEASES; DRUGS; ENDOCRINE DISEASES; GLANDS; HEXOSES; METABOLIC DISEASES; MONOSACCHARIDES; NUCLEIC ACIDS; ORGANIC COMPOUNDS; ORGANS; PATHOLOGICAL CHANGES; PROTEINS; SACCHARIDES
Optional Information
- Copyright
- Copyright (c) 2015 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.